Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>A=Coleman, C. Norman$<.>)
Общее количество найденных документов : 40
Показаны документы с 1 по 20
 1-20    21-40  
1.
Coleman C.Norman Hypoxia in tumors: a paradigm for the approach to biochemical and physilodic heterogenity // J. Nat. Cancer Inst., 1988. Vol. 80, N 5.-С.310-317

2.
Harris Jay R. Estimating the risk of second primary tumors following cancer treatment // J. Clin. Oncol., 1989. Vol. 7, N 1.-С.5-6

3.
Stevenson Effects of nitroimidazoles on neuronal cells in vitro // Int. J. Radiat., Oncol., Biol., Phys., 1989. Vol. 16, N 5.-С.1225-1230

4.
Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): A radiation therapy oncology group study // Int. J. Radiat., Oncol. Biol., Phys., 1989. Vol. 16, N 4.-С.1085-1087А

5.
Radioimmunotherapy with alpha-particle-emitting immunoconjugates // Science, 1988. Vol. 240, N 4855.-С.1024-1026

6.
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole // Caucer Res., 1988. Vol. 48, N 12.-С.3528-3532

7.
Radiation Injury Treatment Network (RITN): Healthcare professionals preparing for a mass casualty radiological or nuclear incident // Int. J. Radiat. Biol., 2011. Vol. 87, N 8.-С.748-753

8.
Coleman C.Norman Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity // J. Nat. Cancer Inst., 1988. Vol. 80, N 5.-С.310-317

9.
Combined modality therapy using cytotoxic agents and radiation therapy // Amer. J. Clin. Oncol., 1988. Vol. 11, N 3.-С.304-312

10.
Improved methodology for analyzing local and distant recurrence // J. Clin. Oncol., 1990. Vol. 8, N 3.-С.548-555

11.
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma // J. Nat. Cancer Inst., 1992. Vol. 84, N 3.-С.187-193

12.
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients // Environ. and Mol. Mutagenes, 1991. Vol. 18, N 1.-С.6-13

13.
Radiation- induced brain damage, impact of Michael Robbins' work and the need for predictive biomarkers // Int. J. Radiat. Biol., 2014. Vol. 90, N 9.-С.742-752

14.
X-irradiation, phorbol esters, and H[2]O[2] stimulate mitogen-activated protein kinase activity in NIH-3Т3 cells through the formation of reactive oxygen intermediates // Cancer Res., 1994. Vol. 54, N 1.-С.12-15

15.
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) radiation therapy oncology group 83-03 // Int. J. Radiat., Oncol. Biol., Phys., 1990. Vol. 18, N 2.-С.389-393

16.
Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma // J. Nat. Cancer Inst, 1990. Vol. 82, N 24.-С.1918-1921

17.
Herman Terence S. Interaction of SR-4233 with hyperthermia and radiatc murine fibrosarcoma tumor system in vitro and in vivo // Cancer Res., 1990. Vol. 50, N 16.-С.5055-5059

18.
Modulation of alkylating agents by etanidazole and fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma // Cancer Res., 1991. Vol. 51, N 4.-С.1044-1091

19.
Prognostic factors for positive surgical staging in patients with Hodgkin's disease // J. Clin. Oncol., 1990. Vol. 8, N 2.-С.257-265

20.
Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-'каппа'B-responsive genes // J. Immunol., 1999. Vol. 163, N 10.-С.5608-5616

 1-20    21-40  
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)